Mots-clés
Organismes > OEDT
OEDTSynonyme(s)Observatoire européen des drogues et des toxicomanies European Monitoring Centre for Drugs and Drug Addiction |
Documents disponibles dans cette catégorie (436)
Document texte divers
This table, a working document, lists approximately 500 substances controlled by the EU Member States and Norway, and aims to provide an at-a-glance guide as to where and if the substance is controlled within each country's legal system. Its Exc[...]Rapport
All countries use legal or judicial means to grade the severity of the offence of drug possession and related actions. Frequently this is done by reference to the quantity of drugs involved in the offence, and some countries choose to indicate c[...]Rapport
As involvement with drugs rises amongst young people under the age of 18, this study looks at the various national laws across the EU and candidate countries that aim to address this issue. The study concentrates on legislation covering three as[...]Rapport
Commission des communautés européennes = Commission of the European communities | Luxembourg : Commission des Communautés Européennes / Commission of the European Communities | 1993The feasibility of a tran-European network for monitoring drugs issues has been established on both technological and social-cognitive grounds. In the technological domain, it has been shown that centres throughout the European Community can be [...]Rapport
Commission des communautés européennes = Commission of the European communities | Luxembourg : Commission des Communautés Européennes / Commission of the European Communities | 1992La phase III de l'étude de faisabilité de l'Observatoire Européen des Drogues (EMCDDA) précise le cadre technique du réseau REITOX (Réseau Européen d'Information sur les Drogues et les Toxicomanies) dont les objectifs étaient définis dans l'étud[...]Rapport
ENGLISH: This handbook has been developed with the primary purpose of providing specific reference material for the European Prevention Curriculum (EUPC) training courses. It also serves to provide a more general introduction to prevention scie[...]Rapport
FRANÇAIS : Ce rapport fournit une analyse descriptive du contexte historique, du cadre opérationnel et du bilan des services permettant une consommation de drogue contrôlée. A partir d'une revue de la littérature, il vise à sensibiliser l'opin[...]Rapport
Article 5.1 of Council Decision 2005/387/JHA (hereinafter referred to as the 'Decision') stipulates that 'Where Europol and the EMCDDA, or the Council, acting by a majority of its members, consider that the information provided by the Member Sta[...]Rapport
This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature. Reco[...]Livre
M. NILSON ; G. BURKHART ; C. KROGER ; H. WINTER ; O. BAKER ; J. MOUNTENEY ; NEAMAN R. | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 1998FRANÇAIS : Cette monographie reprend les conclusions de la première conférence européenne sur l'évaluation de la prévention contre la drogue. La première partie est centrée sur l'histoire, les fondements et l'évaluation de la recherche en mati[...]Livre
M. NILSON ; A. KOKKEVI ; P. P. MERINO ; BLUM M. | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 1999FRANÇAIS : En raison de l'augmentation des problèmes liés à la drogue et des moyens financiers limités qui leur sont affectés, la nécessité de gérer efficacement les coûts des traitements et d'obtenir les résultats les meilleurs au moindre coû[...]Livre
Commission européenne = European Commission ; NEAMAN R. ; M. NILSON ; SOLBERG U., Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2000FRANÇAIS : Cette monographie constitue les actes de la seconde conférence européenne "L'évaluation : un outil clef pour l'amélioration de la prévention de l'usage de drogues" qui s'est tenue à Strasbourg du 2 au 4 décembre 1999. Celle-ci avait[...]Rapport
FRANÇAIS : Ce rapport décrit les résultats de l'évaluation des mécanismes mis en place lors de l'adoption de "l'action commune relative à l'échange d'informations, à l'évaluation des risques et au contrôle des nouvelles drogues de synthèse", l[...]Article : Périodique
FRANÇAIS : 1. L'évaluation est une condition essentielle de la transparence et de la légitimité de l'action publique. Dans le cas des drogues, domaine reconnu pour son caractère controversé et complexe, l'évaluation est, en outre, un des outil[...]Rapport
This short report presents a brief overview of recent evidence for the most effective approaches in the fields of drug use prevention, drug use treatment and harm reduction. It discusses the strengths and limitations of the evidence and some cha[...]Rapport
In the period 2010-2014, the South American cocaine markets have witnessed some change in comparison to previous years, particularly with respect to (a) the estimated areas under coca bush cultivation and the potential volume of cocaine hydrochl[...]Chapitre
This Selected issue looks both at drug use among socially excluded populations (prisoners, immigrants, the homeless, sex workers and vulnerable young people) and social exclusion among drug addicts.Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]Rapport
P. BLANKEN ; C. CARPENTIER ; J. M. COSTES ; S. DIEMEL ; J. GAMELLA ; P. GRIFFITHS ; R. HARTNOLL ; N. HUNT ; J. MOUNTENEY ; C. MUTATAYI ; A. ALVAREZ ROLDAN ; J. SHERVAL ; R. SIMON ; L. VINGOE | Lisbon : OEDT / EMCDDA | 1999Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. EVANS-BROWN ; I. GIRAUDON | Lisbon : OEDT / EMCDDA | Technical reports | 2012The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability [...]Article : Périodique
Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. Recent concerns have arisen around the illicit use of fentanyl and its analogues in a number of European countries, linked to their high potency an[...]Congrès
First European conference on drug supply indicators (20-22 October 2010; Brussels, Belgium) | Lisbon : OEDT / EMCDDA | Conference proceedings | 2010The conference was organised around three main thematic areas: the drug market, the drug-crime nexus, and drug supply reduction. In practical terms, the conference provided an opportunity to assess the current state of the art in data availabili[...]Article : Périodique
FRANÇAIS : Si l'information produite par les agences est si cruciale au mouvement de convergence des politiques nationales, il paraît décisif de comprendre comment elle exerce son pouvoir de persuasion, c'est-à-dire comment elle en vient à être[...]Rapport
Rapport
This report presents the overview of the drug phenomenon in France, covering drug supply, use and public health problems, as well as drug policy and responses. The statistical data reported relate to 2016 (or most recent year) and are provided t[...]Article : Périodique
R. ANDREWS ; R. JORGE ; R. CHRISTIE ; A. GALLEGOS |With new synthetic cannabinoids (SC) appearing on the European drug market every year, early warning systems are key to detect, monitor, and respond to threats posed by them. The European Union Early Warning System (EU EWS) implemented by the Eu[...]Rapport
In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylf[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the ba[...]Article : Périodique
L. MONTANARI ; M. SERAFINI ; E. MAFFLI ; M. BUSCH ; K. KONTOGEORGIOU ; W. KUIJPERS ; A. OUWEHAND ; M. POULOUDI ; R. SIMON ; M. SPYROPOULOU ; B. STUDNICKOVA ; V. A. GYARMATHY |Aims: To assesses the extent of the gender gap among the treated population of drug users across Europe. Methods: This analysis reports data on 363,170 clients from 4647 treatment units in 23 countries (22 European Union member states and Switze[...]Chapitre
The influence of gender not only on patterns and levels of drug consumption in Europe but also on how responses to drug problems are planned and implemented is explored in this Selected issue. Based on a scientific analysis of the available data[...]Article : Périodique
FRANÇAIS : Cet article propose une nouvelle approche des groupes d'experts qu'il situe par rapport à la littérature internationale portant sur l'expertise, le rôle des savoirs et le gouvernement par comités dans l'Union européenne. Il en examin[...]Rapport
OEDT = EMCDDA ; ONUDC / UNODC | New York : UNODC/UNODCCP | Programme mondial d'évaluation de l'abus de drogues / Global Assessment Programme on drug abuse (GAP) | 2007The number of people seeking treatment for drug problems is a leading indicator of drug use patterns and prevalence. Data collected from this group offer a valuable 'window' onto an otherwise hidden population and a means of assessing the perfor[...]Rapport
Rapport
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of ri[...]Rapport
Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug use that cannot be reliably measured by surveys. T[...]Rapport
At least 1.1 million Europeans are estimated to have received treatment for drug dependence during 2009, mostly through opioid substitution, detoxification and psychosocial interventions, delivered in a variety of settings. While more than half [...]Rapport
OEDT = EMCDDA ; J. HILLEBRAND ; D. OLSZEWSKI ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2006FRANÇAIS : Cette étude thématique met en évidence un intérêt croissant des jeunes européens pour l'expérimentation des champignons hallucinogènes. Les enquêtes menées auprès d'élèves scolarisés (15-16 ans) montrent que la prévalence de l'usage[...]Rapport
ENGLISH : This Handbook is intended to be a reference toolbox for everyone planning, organising or executing a survey about drug use among the general population. The Handbook is, to a large extent, a compilation, summary and editing of the fi[...]Livre
T. RHODES ; D. HEDRICH, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2010Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from different perspectives, including international organisations, academic researchers and drug users. Part II is de[...]Document multimédia
FRANÇAIS : L'OEDT vient d'ajouter sur son site une section présentant une vue d'ensemble des pratiques de réduction des méfaits pour 30 pays européens. Pour chacun des pays, on peut trouver : • une description du contexte national ; • une de[...]Document multimédia
The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use. The guide is composed of four sets of miniguides that look at resp[...]Rapport
FRANÇAIS : Comment répondre aux problèmes des héroïnomanes âgés ? Comment lutter contre les décès causés par le fentanyl et ses dérivés extrêmement puissants ? Comment prévenir les risques dus à la consommation d'alcool et de drogues lors des f[...]Rapport
This report is designed to provide the participants of the seminar and the institutions of the European Community with a concise document upon which to base future drug demand reduction initiatives in the field of epidemiology. It is comprised m[...]Rapport
OEDT = EMCDDA ; A. PIRONA ; A. ATKINSON ; H. SUMNALL | Lisbon : OEDT / EMCDDA | Rapid communication | 2016FRANÇAIS : Bien que l'usage de NPS en Europe demeure relativement faible, l'EMCDDA s'alarme des risques liés à la consommation de ces substances. Les données récentes mettent en évidence que les NPS sont à l'origine d'urgences hospitalières et [...]Article : Périodique
FRANÇAIS : L'hépatite C est devenue ces dernières années l'une des principales menaces pour la santé publique mondiale. L'Union européenne compterait plus d'un million de porteurs mais, en l'absence de données précises, il est possible que ce [...]Rapport
OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]Livre
JAGER J. ; LIMBURG W. ; M. KRETZSCHMAR ; POSTMA M. ; L. WIESSING, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2004ENGLISH : Hepatitis C infections occurring in recent years in the European Union may cost countries billions of euros in future healthcare, according to research published in this monograph. A conglomeration of state-of-the-art research on he[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2017This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]Rapport
FRANÇAIS : Les données des services d'urgences hospitalières montrent que, chaque année, en Europe, des milliers de personnes subissent des empoisonnements et autres problèmes liés aux drogues qui nécessitent une forme d'assistance médicale. Da[...]Article : Périodique
A. UHL ; G. HUNT ; W. VAN DEN BRINK ; G. V. STIMSON |An important aspect of understanding the dynamics of substance use in societies is to study how traditions, fashions and policy interventions impact upon substance use and related problems. Since large, well-controlled, long-term policy experime[...]Article : Périodique
'Spice' is a herbal mixture sold on the internet, samples of which have been found to contain new synthetic drugs which produce effects similar to cannabis. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)'s early warning sys[...]Article : Périodique
In April 2023, the Taliban banned poppy cultivation and the trade of all narcotics. This caused a 95% reduction in opium production. Usually, that would be good news. But there is a substantial worry: synthetic opioids might fill the void left b[...]Article : Périodique
D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR |In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Roman[...]Article : Périodique
V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO |COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]Rapport
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2021Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]Rapport
OEDT = EMCDDA ; J. FOUNTAIN ; G. BURKHART ; L. MONTANARI | Lisbon : OEDT / EMCDDA | Technical reports | 2017This report provides an overview of the various types of brief interventions (BIs) currently used in European countries in the field of substance use, particularly illicit drugs. Targeted at policymakers and practitioners alike, it covers more t[...]Rapport
This report provides a summary of the key findings from the assessment of progress of the EU Member States, Norway and Turkey towards the implementation of the revised drug supply indicators, as developed by the EMCDDA in line with the Council c[...]Rapport
ENGLISH : This report presents the results of a European project to improve the comparability of general population surveys on drug use prevalence. The project was commissioned by the EMCDDA and carried out by O+S Amsterdam, in close cooperati[...]Article : Périodique
Changing the severity of statutory penalties for cannabis use offences does not appear to have a consistent impact on cannabis use by young adults, and new policy responses to the proliferation of new psychoactive substances within European coun[...]Rapport
OEDT = EMCDDA ; D. HEDRICH ; K. PALCZAK ; K. KEPA ; N. SINGLETON | Lisbon : OEDT / EMCDDA | Manuals | 2021This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment[...]Article : Périodique
May 2014 saw the launch of the European drug report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDAs) annual review of the European drug market, incorporating trend analysis, topic overviews, statistical data and ind[...]Article : Périodique
ENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]Article : Périodique
G. BURKHART, Personne interviewée ; M. PORTNER-HELFER, Intervieweur |En matière de stratégie de prévention, il est souvent question de campagnes d'information à large échelle ou de mesures ciblées destinées à modifier les comportements des individus par rapport à leur consommation. En agissant davantage sur l'env[...]Rapport
Commission des communautés européennes = Commission of the European communities ; OEDT = EMCDDA | 1993FRANÇAIS : Ce document constitue un recueil de la majorité des textes officiels de la communauté européenne depuis environ vingt ans. Il s'agit d'une des premières publications de l'Observatoire Européen des Drogues dont les objectifs et l'org[...]Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2020This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on [...]Rapport
The aim of this paper is to focus on the harmful interaction between psychoactive drug use and sexual activity. It is acknowledged that in some individuals co-occurrence of drug consumption and sexual activity causes no apparent harm, but this g[...]Article : Périodique
P. GRIFFITHS ; D. LOPEZ ; R. SEDEFOV ; A. GALLEGOS ; B. HUGHES ; A. NOOR ; L. ROYUELA |AIM OF THE STUDY: To review the information available on the use of khat (Catha edulis) in the EU, and to assess the future use of this drug and related substances. MATERIAL AND METHODS: Khat is not controlled by international law and it has not[...]Article : Périodique
Background: Registries for drug deaths may include different persons and provide different characteristics of the deceased. The aim of this study was to establish whether a database of drug-induced deaths (Cause of Death Registry (CDR) using the[...]NouveautéRapport
FRANÇAIS : Cette synthèse de la littérature compare les différents modes de consommation de drogues, la conduite sous influence et les accidents de la route. Elle décrit également les procédures de dépistage des drogues, les législations exist[...]Brochure
In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing the drug situation in 1995 and leads us, over key m[...]Rapport
The open sale of cannabis products in Europe has raised concerns among policymakers, both with regard to the legal status of these products and their potential for harm. The products are marketed for their low THC (tetrahydrocannabinol) content,[...]Article : Périodique
The European Monitoring Centre for Drugs and Drug Addiction, EMCDDA, publishes statistics for overdose deaths giving a European mean number, and ranking nations in a national 'league table' for overdose deaths. The interpretation of differing na[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : L'usage de drogue est associé directement et indirectement à une grande diversité de conséquences négatives sur la santé et la vie sociale. Ces problèmes concernent dans une mesure disproportionnée les usagers d'opiacés de longue dur[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en-PINACA. The report is intended for policymakers and decision-makers in the inst[...]Rapport
OEDT = EMCDDA ; A. M. DINES ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (MDPV), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Congrès
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs (21-22 November 2013; Tallinn) ; OEDT = EMCDDA, Organisateur de réunion ; European Centre for Disease Prevention and Control, Organisateur de réunion | Lisbon : OEDT / EMCDDA | 2013This meeting, a regional Reitox Academy held in Tallinn (21-22 November 2013) contributed to maximising synergies at national level between institutions and experts in the fields of drug monitoring and infectious disease surveillance in four cou[...]Rapport
Internet and Drugs expert meeting (7 and 8 June 2016; Brussels) | Brussels : European Commission, Directorate-General Migration and Home Affairs | 2016In June 2016, in the framework of the EU Internet Forum, DG HOME organised an expert meeting on internet and drugs. The main points addressed were: analysis of the problem we are confronted with and finding a common definition for it; looking cl[...]Congrès
3rd Meeting on detecting and responding to outbreaks of HIV among people who inject drugs (18 November 2013; Bucharest) ; Roundtable on the HIV situation among people who inject drugs in Romania (19 November 2013; Bucharest) ; OEDT = EMCDDA, Organisateur de réunion ; European Centre for Disease Prevention and Control, Organisateur de réunion | Lisbon : OEDT / EMCDDA | 2013This expert meeting held in Bucharest (18-19 November 2013) provided an important opportunity for sharing knowledge and best practice among experts from six countries in the south and south-east of the European region (Cyprus, Greece, Hungary, M[...]Article : Périodique
FRANÇAIS : Cette livraison résume certaines idées actuelles sur l'utilisation des indicateurs de la prévalence et de l'incidence pour aider à l'élaboration de la politique de l'UE sur les drogues. Il suggère d'autres sources pour ceux qui souh[...]Rapport
This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances. This study focuses on the supply and us[...]Rapport
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution.Rapport
OEDT = EMCDDA ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Rapport
This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. O[...]Rapport
Unusually high numbers of migrants have moved to Europe in recent years, with about 1.2 million people applying for asylum in the European Union in each of the years 2015 and 2016. Fears have been expressed that this group's health status and po[...]Livre
C. GODFREY ; L. WIESSING ; R. HARTNOLL, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2001FRANÇAIS : La modélisation est un moyen technique de simplifier des processus complexes. Ceci est accompli grâce à l'informatique et l'utilisation de formules mathématiques décrivant de manière quantitative les éléments constituant le processu[...]Rapport
S. ARNAUD ; J. P. GERVASONI ; F. DUBOIS-ARBER | Lausanne : Unisanté - Centre universitaire de médecine générale et santé publique | Raisons de santé, ISSN 1660-7104 | 2010Le Monitorage national des dépendances (ou Addiction Monitoring in Switzerland - AMIS) répond à un appel d’offre de l’Office de la santé publique (OFSP). Il a pour but d’identifier les besoins en matière d’indicateurs de surveillance dans le dom[...]Rapport
FRANÇAIS : Ce rapport explore la manière dont, à travers des enquêtes sur des populations ciblées, sont recueillies des données sur l'usage de drogues dans l'espace récréatif public (pubs, bars, clubs, scènes musicales) et privé en Europe. Il r[...]Article : Périodique
D. RHUMORBARBE ; M. MORELATO ; L. STAEHLI ; C. ROUX ; D. O. JAQUET-CHIFFELLE ; Q. ROSSY ; P. ESSEIVA |Background: The rapid emergence of new psychoactive substances (NPS) is a challenge for public health authorities and law enforcement. The phenomenon is strengthened since the increase of the Internet usage. Not only used to trade NPS, the Web i[...]Rapport
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together w[...]Rapport
L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008Growing cocaine use in several EU countries, and increased seizures of cocaine on air, sea and land routes, have become subjects of increasing concern to policymakers. This datasheet provides a short review of key issues relating to how cocaine [...]Rapport
L. LANIEL ; D. LOPEZ ; J. WRIGHT ; C. CARPENTIER ; D. MANSFIELD ; L. ROYUELA ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008ENGLISH : In recent years, anxiety in Europe has increased about the impact of record opium harvests in Afghanistan, and a decrease in heroin retail prices. This datasheet provides a condensed review of the key issues about how heroin manufact[...]Rapport
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological indicator wi[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2015This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]Article : Périodique
H. LOPEZ-PELAYO ; J. VICENTE ; A. GALLEGOS ; A. McAULEY ; Y. BUYUK ; M. WHITE ; I. GIRAUDON |Background-Aims: New psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the drug conventions of the United Nations. In the last 10 years, numerous NPS have been identified in Europe but there is no co[...]Rapport
This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented. The publication begins with an introduction to mortality cohort studi[...]Rapport
This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of the publicatio[...]Rapport
FRANÇAIS : Cette « Question particulière » de l'OEDT concernant la recherche nationale en matière de drogue en Europe décrit brièvement le cadre dans lequel la recherche en matière de drogue est menée dans les pays européens. Elle examine plus[...]Rapport
R. SIMON ; L. KRAUS ; R. BAUERNFEIND ; B. BIELEMAN ; J. M. COSTES ; F. MARIANI ; B. OLSSON ; L. WIESSING | Munich : IFT | 1996A work group was installed in order to support the development of methods for the estimation of prevalence of problematic drug use at national level. Participants of this group were experts, which had been involved in national estimation procedu[...]Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2021This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in E[...]